LyophilisedDUL
Dulaglutide
Bulk≥99.5% Purity
Pharmaceutical-grade dulaglutide for once-weekly GLP-1 receptor agonist therapy.
Request a Quote
Pricing available for qualified medical professionals, clinics, and distributors.
Enquire NowDownload MonographView FAQMechanism of Action
Dulaglutide consists of a GLP-1 analogue covalently linked to a modified IgG4 Fc fragment via a peptide linker. This Fc fusion design extends the half-life to ~5 days for weekly dosing. It activates GLP-1 receptors for glycaemic control and has demonstrated cardiovascular risk reduction in the REWIND trial.
Clinical Benefits
- Once-weekly GLP-1 receptor agonism
- IgG4 Fc fusion for extended half-life
- Supports glycaemic control and weight management
- Cardiovascular risk reduction demonstrated in REWIND trial
Specifications
MechanismGLP-1-IgG4 Fc fusion
Half-life~5 days (weekly dosing)
Purity≥99.5%
Storage & Handling
- Store at 2–8°C
- Protect from light
For professional medical use only. Not for retail sale to the general public. Pricing available on request for qualified medical institutions and distributors.